Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer
Dr. Hope Rugo discusses the chemotherapy agent, Eribulin and the results of a recent study focused on breast cancer patients with advanced disease. We also question if she thinks this is the end for chemotherapy agents in the treatment of breast cancer? This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium.
Dr. Rugo is a Clinical Professor in the Department of Medicine, Director of Breast Oncology and Clinical Trials Education at the University of California San Francisco, Helen Diller Family Comprehensive Cancer Center.
The Group Room at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium was made possible by support from:
